Why the study?
When the coaptation gap becomes too large for TEER in patients with severe symptomatic tricuspid regurgitation, caval valve implantation emerges as a better option.
Does caval valve implantation with the TricValve system improve functional class and right ventricular function in high-risk patients with severe symptomatic tricuspid regurgitation?
Does caval valve implantation with the TricValve system improve functional class and right ventricular function in high-risk patients with severe symptomatic tricuspid regurgitation?
Caval valve implantation with the TricValve system, guided by CT angiography, may be a safe and effective option for improving functional status and right ventricular function in high-risk patients with severe tricuspid regurgitation unsuitable for edge-to-edge repair.
Answers are grounded in this paper and cite their sources.
May support TricValve CAVI feasibility in high-risk TR ineligible for TEER; hypothesis-generating and requires prospective validation.
Less invasive transcatheter tricuspid therapies are optimal alternative for surgery in high-risk individuals with severe symptomatic tricuspid regurgitation on medical therapy.Various techniques are available with Transcatheter Edge-to-Edge Repair (TEER) having the greatest experience worldwide.When the coaptation gap becomes too large for TEER, caval valve implantation (CAVI) emerge as a better option.We described a series of 4 patients who underwent CAVI with the TricValve system and periprocedural computed tomography angiography imaging for the purpose of TricValve sizing.There were few procedural complications, with significant improvements in New York Heart Association functional class and right ventricular function post-procedure.
No takes yet. Share an insight, caveat, or question.
Malreddy et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: